Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma

Kenchappa, R. S., Dovas, A., Argenziano, M. G., Meyer, C. T., Stopfer, L. E., Banu, M. A., Pereira, B., Griffith, J., Mohammad, A., Talele, S., Haddock, A., Zarco, N., Elmquist, W., White, F., Quaranta, V., Sims, P., Canoll, P., & Rosenfeld, S. S. (2022). Activation of STAT3 through combined SRC and EGFR signaling drives resistance to a mitotic kinesin inhibitor in glioblastoma. Cell Reports, 39(12), 110991. https://doi.org/10.1016/j.celrep.2022.110991
Authors:
Rajappa S Kenchappa
Athanassios Dovas
Michael G Argenziano
Christian T Meyer
Lauren E Stopfer
Matei A Banu
Brianna Pereira
Jessica Griffith
Afroz Mohammad
Surabhi Talele
Ashley Haddock
Natanael Zarco
William Elmquist
Forest White
Vito Quaranta
Peter Sims
Peter Canoll
Steven S Rosenfeld
Affiliated Authors:
Athanassios Dovas
Michael G Argenziano
Matei A Banu
Brianna Pereira
Peter Sims
Peter Canoll
Subjects:
Author Keywords:
cp: cancer
egfr
glioblastoma
inhibitor
kinesin
src
stat3
Publication Type:
Article
Unique ID:
10.1016/j.celrep.2022.110991
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: